News Scancell expands cancer research deal with Karolinska Instit... Research will develop drugs in a wider range of cancers
Partner Content Partner Content Immuno-Oncology challenges include identifying patients befo... Challenges facing Immuno-Oncology industry
News EU regulators reject new use for Opdivo, as Keytruda edges a... Keytruda begins to win battle of the immunotherapies
News Lung cancer drug Keytruda to become routinely available on N... NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
